IO Informatics

IO Informatics has begun beta testing a new iteration of the Sentient software suite with pharma partners ahead of a formal launch planned for the first quarter of 2016.

Charles Mead, a member of IO Informatics' scientific advisory board (

This article has been changed to state the Peter Elkin worked for Mount Sinai in the past and not currently as reported earlier

Certara has released D360 7.0, the latest version of its data query, analysis, and visualization solution.

Increasing activity from sequencing vendors and other new players, as well as a flurry of activity around clinical data analysis software and the commercialization of a number of open source tools were the key trends in the bioinformatics community in 2012.

IO Informatics this week launched a new business arm, dubbed IO Healthcare, that will focus on helping customers in the personalized medicine market use clinical information to enhance their research and development activities.

The Center of Excellence for the Prevention of Organ Failure, or PROOF Center, has tapped semantics-based software developer IO Informatics to build a web-based application that will be able to assess patients’ disease risk and make treatment recommendations.

NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure, or PROOF Centre, and IO Informatics today announced a deal to develop a web-based software application addressing chronic heart, lung, and kidney disease.

By Uduak Grace Thomas
This article has been updated from a version posted March 6 to include comments from IO Informatics and Sage-N Research officials.

Pages

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.